Your browser doesn't support javascript.
loading
Effect of metformin treatment in patients with type 2 diabetes with respect to glyoxalase 1 activity in atherosclerotic lesions.
Peters, Andreas S; Wortmann, Markus; Fleming, Thomas H; Nawroth, Peter P; Bruckner, Thomas; Böckler, Dittmar; Hakimi, Maani.
Affiliation
  • Peters AS; 1 Department of Vascular and Endovascular Surgery Heidelberg, University Hospital Heidelberg, Germany.
  • Wortmann M; 4 Vaskuläre Biomaterialbank Heidelberg, VBBH (Vascular Biomaterialbank Heidelberg), University of Heidelberg, Germany.
  • Fleming TH; 1 Department of Vascular and Endovascular Surgery Heidelberg, University Hospital Heidelberg, Germany.
  • Nawroth PP; 4 Vaskuläre Biomaterialbank Heidelberg, VBBH (Vascular Biomaterialbank Heidelberg), University of Heidelberg, Germany.
  • Bruckner T; 2 Department of Internal Medicine I and Clinical Chemistry Heidelberg, University Hospital Heidelberg, Germany.
  • Böckler D; 5 German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Hakimi M; 2 Department of Internal Medicine I and Clinical Chemistry Heidelberg, University Hospital Heidelberg, Germany.
Vasa ; 48(2): 186-192, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30421661

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Atherosclerosis / Metformin Limits: Aged / Female / Humans / Male Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Atherosclerosis / Metformin Limits: Aged / Female / Humans / Male Language: En Year: 2019 Type: Article